logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11549152 B1

PDFFull Text
Date of Patent:
Jan. 10, 2023

Filed:

Mar. 07, 2019

Products for assessing colorectal cancer molecular subtype and risk of recurrence and for determining and administering treatment protocols based thereon

Applicant:

University of Notre Dame Du Lac, South Bend, IN (US);

Inventor:

Steven Buechler, Granger, IN (US);

Assignee:

University of Notre Dame du Lac, South Bend, IN (US);

Attorneys:

Denise L. Mayfield

Dykema Gossett PLLC

Primary Examiner:

Joseph G Dauner

Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); G16H 20/40 (2018.01); G16H 70/60 (2018.01); G16H 10/40 (2018.01); G16H 50/20 (2018.01); G16B 25/10 (2019.01); G16B 40/00 (2019.01); G16B 30/00 (2019.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); G16B 25/10 (2019.02); G16B 30/00 (2019.02); G16B 40/00 (2019.02); G16H 10/40 (2018.01); G16H 20/40 (2018.01); G16H 50/20 (2018.01); G16H 70/60 (2018.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01);
Abstract

Products, systems, and methods for classifying human colorectal cancer into a consensus molecular subtype (CMS) and for assessing risk of recurrence based on CMS scores and based on risk scores derived from abbreviated gene expression profiles, for determining suitable treatment protocols for human colorectal cancer patients based on the determined CMS classification and based on the determined risk of recurrence, and for administering the suitable treatment protocols.

Find Patent Forward Citations

Buechler, Steven. (2023). Products for assessing colorectal cancer molecular subtype and risk of recurrence and for determining and administering treatment protocols based thereon (U.S. Patent No. 11549152). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11549152

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…